Black Diamond Therapeutics, Inc. SEC filings BDTX
Black Diamond Therapeutics, Inc. has 485 filings in SEC EDGAR's recent list, going back to Mar 28, 2017. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Dec 3, 2025 | — |
| CORRESP | Letter to the SEC | Dec 1, 2025 | — |
| EFFECT | Filing | Nov 22, 2022 | — |
| CORRESP | Letter to the SEC | Nov 18, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 17, 2022 | — |
| EFFECT | Filing | Jan 29, 2020 | — |
| CERT | Filing | Jan 29, 2020 | — |
| 8-A12B | Filing | Jan 27, 2020 | — |
| CORRESP | Letter to the SEC | Jan 27, 2020 | — |
| CORRESP | Letter to the SEC | Jan 27, 2020 | — |
| CORRESP | Letter to the SEC | Jan 21, 2020 | — |
| CORRESP | Letter to the SEC | Jan 13, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 10, 2020 | — |
| DRS/A | Filing | Dec 13, 2019 | — |
| D | Filing | Dec 6, 2019 | — |
| DRSLTR | Filing | Oct 30, 2019 | — |
| DRS/A | Filing | Oct 30, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 17, 2019 | — |
| SEC STAFF LETTER | Filing | Oct 17, 2019 | — |
| DRSLTR | Filing | Oct 7, 2019 | — |
| DRS/A | Filing | Oct 7, 2019 | — |
| SEC STAFF LETTER | Filing | Sep 19, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 19, 2019 | — |
| DRS | Filing | Aug 23, 2019 | — |
| D/A | Filing | Jul 16, 2019 | — |
| D | Filing | Jan 3, 2019 | — |
| D | Filing | Aug 22, 2018 | — |
| D/A | Filing | Jan 4, 2018 | — |
| D | Filing | Mar 28, 2017 | — |
Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BDTX (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1701541
- Former names
- Aset Therapeutics, Inc. (until Jan 4, 2018)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.